Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about a recent article by Shashank Shekhar et al., published in Journal of Cardiothoracic and Vascular Anesthesia, adding:
“Cardiogenic shock remains one of the greatest challenges in cardiovascular medicine, with mortality still reaching 30–60% despite advances in reperfusion and mechanical circulatory support.
This updated review highlights a major shift in our approach: moving beyond simply treating hypotension toward recognizing shock early, using structured SCAI staging, invasive hemodynamic assessment, and multidisciplinary shock teams to personalize therapy.
Mechanical circulatory support is not a universal solution – timing, patient selection, and continuous reassessment are what truly determine outcomes.
As our understanding of shock physiology evolves, the future lies in precision medicine: identifying the right patient, selecting the right device, and intervening before irreversible organ injury occurs.
Which aspect of cardiogenic shock management do you think will have the greatest impact over the next decade: earlier diagnosis, invasive hemodynamic monitoring, or newer mechanical circulatory support strategies?”
Title: Cardiogenic Shock: Current Evidence, Guideline Perspectives, and Outcomes
Authors: Shashank Shekhar, Ankit Agrawal, Hussein Almadhoun, Patrick M. Wieruszewski, Gauranga Mahalwar, Tikal Kansara, James A. Nelson, Steven T. Morozowich, Ivan Nunez Gil, Seshasayee Narasimhan, Harish Ramakrishna, Omar Elmadhoun
Other posts featuring Alejandro González Veliz on Hemostasis Today.
-
Sep 24, 2026, 16:02Leonardo Roever: Understanding Peripheral Artery Disease in the Modern Era
-
Sep 24, 2026, 15:49Sthanu Subramanian: When HbA1c Does Not Reflect True Glycemia
-
Sep 24, 2026, 15:09Caroline Voltz-Girolt: Accelerating the Development of Innovative Therapies for Rare Blood Disorders
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care